Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 23, 2023 - Issue 6
Submit an article Journal homepage
1,468
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Real-world healthcare costs and resource utilization in patients with von Willebrand disease and angiodysplasia

NT Connella Hematology Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0003-4100-7826View further author information
ORCID Icon,
J Caicedob US Medical Affairs, Takeda Pharmaceuticals USA Inc, Lexington, MA, USAORCID Iconhttps://orcid.org/0000-0002-5816-568XView further author information
ORCID Icon,
N Nietob US Medical Affairs, Takeda Pharmaceuticals USA Inc, Lexington, MA, USAView further author information
,
S Chatterjeec Complete HEOR Solutions, North Wales, PA, USAORCID Iconhttps://orcid.org/0000-0002-8800-7746View further author information
ORCID Icon,
A Haitc Complete HEOR Solutions, North Wales, PA, USAView further author information
,
AK Guptac Complete HEOR Solutions, North Wales, PA, USAView further author information
,
M Bullanob US Medical Affairs, Takeda Pharmaceuticals USA Inc, Lexington, MA, USAORCID Iconhttps://orcid.org/0000-0002-9961-4576View further author information
ORCID Icon &
BG Schultzb US Medical Affairs, Takeda Pharmaceuticals USA Inc, Lexington, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7023-8378View further author information
ORCID Icon show all
Pages 691-699 | Received 10 Mar 2023, Accepted 26 Apr 2023, Published online: 15 May 2023

References

  • Mannucci P. New therapies for von Willebrand disease. Hematol 2014 Am Soc Hematol Educ Program Book. 2019 Dec 06;2019(1):590–595.
  • Springer T. von Willebrand factor, Jedi knight of the bloodstream. Blood J Am Soc Hematol. 2014 Aug 28;129(9):1412–1425.
  • Mannucci P, Franchini M. Laboratory monitoring of replacement therapy for major surgery in von Willebrand disease. Haemophilia. 2017 Mar;23(2):182–187.
  • Mannucc PM. Treatment of von Willebrand disease. Thromb Haemost. 2001;86(07):149–153.
  • Selvam S, James P. Angiodysplasia in von Willebrand disease: understanding the clinical and basic science. Semin Thromb Hemost. 2017;43(06):572–580.
  • Aghighi M, Taherian M, Sharma A. Angiodysplasia. 2019.
  • Ramsay D, Buist T, Macleod D, et al. Persistent gastrointestinal bleeding due to angiodysplasia of the gut in von Willebrand’s disease. Lancet. 1976;308(7980):275–278.
  • Makris M, Federici A, Mannucci P, et al. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease. Haemophilia. 2015;21(3):338–342.
  • Dray X, Camus M, E A Coelho J. Treatment of gastrointestinal angiodysplasia and unmet needs. Digestive Liver Dis. 2011;43(7):515–522.
  • Rodrigues J, Chivia J, Figueiredo P. Fleeting Angiodysplasia. GE-Portuguese J Gastroenterol. 2018;25(4):203–204.
  • Kuhle W, Sheiman R. Detection of active colonic hemorrhage with use of helical CT: findings in a swine model. Radiology. 2003;228(3):743–752.
  • Raju G, Das GLA, Lewis B. American Gastroenterological Association (AGA) Institute medical position statement on obscure gastrointestinal bleeding. Gastroenterology. 2007;133(5):1694–1696.
  • Vargo JJ. Clinical applications of the argon plasma coagulator. Gastrointest Endosc. 2004;59(1):81–88.
  • Franchini M, Mannucci P. Von Willebrand disease‐associated angiodysplasia: a few answers, still many questions. Br J Haematol. 2013 Apr;161(2):177–182.
  • Chen H, Ge Z, E A Liu W. The mechanisms of thalidomide in treatment of angiodysplasia due to hypoxia. Zhonghua Nei Ke Za Zhi. 2009;48(4):295–298.
  • Eghbali A, Melikof L, Taherahmadi H, et al. Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial. Haemophilia. 2016 Sep;22(5):e423–6.
  • Lu M, Oladapo A, Wu Y, et al. Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States. J Managed Care Specialty Pharm. 2021;27(2):175–185.
  • Oladapo A, Wu Y, Lu M, et al. Economic burden associated with major surgery in patients with von Willebrand disease: a United States retrospective administrative database analysis. J Blood Med. 2021;12:699–708.
  • IBM, [Online]. Ibm. Available from: https://www.ibm.com/products
  • Ogden C, Kuczmarski R, E A Flegal K. Centers for disease control and prevention 2000 growth charts for the United States: improvements to the 1977 national center for health statistics version. Pediatrics. 2002;109(1):45–60.
  • Fryar CD, Kruszon-Moran D, Gu Q, et al. Mean body weight, weight, waist circumference, and body mass index among adults: United States, 1999–2000 through 2015–2016. Natl Health Stat Report. 2018;(122):1–16.
  • Iwagami M, Shinozaki T. Introduction to matching in case-control and cohort studies. Annals of Clin Epidemiol. 2022;4(2):33–40.
  • Yoon S, Shin J, Heo S, et al. Irritable bowel syndrome and subsequent risk of Parkinson’s disease: a nationwide population-based matched-cohort study. J Neurol. 2022;269(3) :1404–1412.
  • Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci a Rev J Inst Math Stat. 2010;25(1). DOI:10.1214/09-STS313
  • James P, Connell N, Ameer B, et al. McRae S. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280–300. DOI:10.1182/bloodadvances.2020003265
  • Schinco P, Cultrera D, Valeri F, et al. Cost–consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context. Clinicoecon Outcomes Res. 2014;7:17–25.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.